We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RANI icon
3951
Rani Therapeutics
RANI
$88.5M
$7 ﹤0.01%
+3
New +$11
SERA icon
3952
Sera Prognostics
SERA
$79.1M
$7 ﹤0.01%
+4
New +$10
SLE icon
3953
Super League Enterprise
SLE
$4.52M
0
PGRU
3954
DELISTED
PropertyGuru Group Limited
PGRU
$7 ﹤0.01%
+2
New +$8
KA
3955
DELISTED
Kineta, Inc. Common Stock
KA
$7 ﹤0.01%
+2
New +$4
BRLT icon
3956
Brilliant Earth
BRLT
$18.4M
$6 ﹤0.01%
+2
New +$7
EARN
3957
Ellington Residential Mortgage REIT
EARN
$168M
$6 ﹤0.01%
+1
New +$7
LFVN icon
3958
LifeVantage
LFVN
$80.5M
$6 ﹤0.01%
+1
New +$6
LPTH icon
3959
Lightpath Technologies
LPTH
$667M
$6 ﹤0.01%
+4
New +$7
MOGU
3960
MOGU Inc
MOGU
$16M
$6 ﹤0.01%
+3
New +$6
RTB
3961
RTB Digital
RTB
$217M
0
SCNI
3962
Scinai Immunotherapeutics
SCNI
$1.24M
$6 ﹤0.01%
+1
New +$13
SXTC icon
3963
China SXT Pharmaceuticals
SXTC
$2.66M
0
TXMD icon
3964
TherapeuticsMD
TXMD
$23.7M
$6 ﹤0.01%
+2
New +$8
NXU
3965
DELISTED
Nxu, Inc. Class A Common Stock
NXU
0
AP icon
3966
Ampco-Pittsburgh
AP
$171M
$5 ﹤0.01%
+2
New +$7
FORA
3967
DELISTED
Forian
FORA
$5 ﹤0.01%
+2
New +$5
KMDA icon
3968
Kamada
KMDA
$402M
$5 ﹤0.01%
+1
New +$5
SCYX icon
3969
SCYNEXIS
SCYX
$37M
0
UAVS icon
3970
AgEagle Aerial Systems
UAVS
$40.7M
0
YQ
3971
17 Education & Technology Group
YQ
$19.9M
$5 ﹤0.01%
+1
New +$4
THMO
3972
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$5 ﹤0.01%
+4
New +$5
ACHV icon
3973
Achieve Life Sciences
ACHV
$635M
$4 ﹤0.01%
+1
New +$5
HOWL icon
3974
Werewolf Therapeutics
HOWL
$20.7M
$4 ﹤0.01%
+2
New +$6
ICAD
3975
DELISTED
iCAD Inc
ICAD
$4 ﹤0.01%
+2
New +$5

Similar funds

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.